Hyaluronic acid-modified Fe-based metal–organic framework loaded with cisplatin for targeted lung cancer therapy
Abstract
= 35.6 ± 0.5 µM) and worked well with BEAS-2B cells (89.31% viability).
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Metal-Organic Frameworks: Synthesis and Applications
Publication details
- Journal / source
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 16
- Issue
- 27
- Pages
- 24838–24851
- Publication date
- 1 January 2026
- Language
- EN